10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2019-11-14 (Q3 2019) | Holdings: 32 | Value: $1.7B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A S | New Purchase | 23.72% | $398.0M | +59.25% | +27.05% | +47.45% | |
| WVE - WAVE LIFE SCIENCES LTD | New Purchase | 9.51% | $159.6M | -76.06% | -70.28% | -70.11% | |
| THOR - SYNTHORX INC | New Purchase | 9.43% | $158.2M | ||||
| RARX - RA PHARMACEUTICALS INC | New Purchase | 6.85% | $114.9M | +0.02% | |||
| ZGNX - ZOGENIX INC | New Purchase | 5.39% | $90.5M | -34.18% | -53.70% | ||
| EIDX - EIDOS THERAPEUTICS INC | New Purchase | 4.63% | $77.8M | +11.94% | +78.25% | ||
| RYTM - RHYTHM PHARMACEUTICALS INC | New Purchase | 4.40% | $73.9M | +204.98% | -16.50% | +0.88% | |
| STSA - SATSUMA PHARMACEUTICALS INC | New Purchase | 4.19% | $70.3M | +71.11% | -75.34% | ||
| ORTX - ORCHARD THERAPEUTICS PLC | New Purchase | 3.70% | $62.1M | +17.58% | -58.05% | ||
| SLDB - SOLID BIOSCIENCES INC | New Purchase | 2.82% | $47.3M | -91.12% | +3.76% | +1.25% | |
| TVTX - RETROPHIN INC | New Purchase | 2.75% | $46.2M | +13.06% | +27.04% | +85.18% | |
| PRVL - PREVAIL THERAPEUTICS INC | New Purchase | 2.46% | $41.3M | +54.84% | -8.14% | ||
| TGTX - TG THERAPEUTICS INC | New Purchase | 2.30% | $38.6M | +386.99% | +96.53% | +265.80% | |
| ARVN - ARVINAS INC | New Purchase | 2.14% | $35.8M | -77.39% | +63.14% | -16.50% | |
| DRNA - DICERNA PHARMACEUTICALS INC | New Purchase | 2.10% | $35.3M | +0.69% | +11.83% | ||
| MYOV - MYOVANT SCIENCES LTD | New Purchase | 1.91% | $32.1M | +92.23% | +215.04% | ||
| CRNX - CRINETICS PHARMACEUTICALS INC | New Purchase | 1.68% | $28.2M | +74.23% | +20.27% | -26.74% | |
| STOK - STOKE THERAPEUTICS INC | New Purchase | 1.43% | $24.1M | -57.91% | +10.95% | +74.16% | |
| SCPH - SCPHARMACEUTICALS INC | New Purchase | 1.14% | $19.1M | -15.26% | +81.24% | +94.02% | |
| KALA - KALA PHARMACEUTICALS INC | New Purchase | 1.03% | $17.3M | -97.72% | +79.45% | +103.29% | |
| DTIL - PRECISION BIOSCIENCES INC | New Purchase | 0.92% | $15.5M | -98.55% | -30.62% | -19.08% | |
| KOD - KODIAK SCIENCES INC | New Purchase | 0.88% | $14.7M | -84.55% | +132.24% | +347.62% | |
| ALEC - ALECTOR INC | New Purchase | 0.86% | $14.4M | -91.02% | +84.65% | -18.92% | |
| AXSM - AXSOME THERAPEUTICS INC | New Purchase | 0.80% | $13.4M | +318.22% | +248.00% | +180.76% | |
| PTLA - PORTOLA PHARMACEUTICALS INC | New Purchase | 0.69% | $11.5M | -49.87% | |||
| DVAX - DYNAVAX TECHNOLOGIES CORP | New Purchase | 0.50% | $8.5M | +69.51% | -12.78% | -24.87% | |
| IGMS - IGM BIOSCIENCES INC | New Purchase | 0.49% | $8.3M | -95.42% | +67.05% | +99.26% | |
| XFOR - X4 PHARMACEUTICALS INC | New Purchase | 0.36% | $6.1M | -99.06% | -22.13% | -49.23% | |
| ODTC - ODONATE THERAPEUTICS INC | New Purchase | 0.31% | $5.2M | -2.34% | -55.44% | ||
| CMRX - CHIMERIX INC | New Purchase | 0.25% | $4.2M | -5.38% | +91.94% | ||
| EPIX - ESSA PHARMA INC | New Purchase | 0.20% | $3.4M | -65.80% | +5.00% | +29.00% | |
| SENS - SENSEONICS HLDGS INC | New Purchase | 0.16% | $2.7M | -39.66% | +54.20% | -56.26% | |